Emmanuel Chautard
Clermont-ferrand, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Tumor immune microenvironment predicts recurrence after radiotherapy in oropharyngeal squamous cell carcinoma.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 03, 2026
Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies.
Journal: Scientific reports
Published: October 20, 2025
Immunomodulatory intraperitoneal chemotherapy with DACHPt-loaded biomaterial nanoparticles in colorectal carcinomatosis.
Journal: Pharmacological research
Published: September 10, 2025
The benefits of combining an immunomodulator with a chemotherapy agent in chondrosarcoma-a proof of concept with mifamurtide.
Journal: Medical oncology (Northwood, London, England)
Published: June 23, 2025
Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual-Tumour Mouse Melanoma Model.
Journal: Experimental dermatology
Published: August 26, 2024
Chondrosarcoma Co-Culture 3D Model─An Insight to Evaluate Drugs Acting on TAMs.
Journal: ACS biomaterials science & engineering
Published: August 09, 2024
Leveraging Deep Learning for Immune Cell Quantification and Prognostic Evaluation in Radiotherapy-Treated Oropharyngeal Squamous Cell Carcinomas.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: July 27, 2024
3D Coculture between Cancer Cells and Macrophages: From Conception to Experimentation.
Journal: ACS biomaterials science & engineering
Published: December 18, 2023
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 28, 2022
The Long Non-Coding RNA HOXA-AS2 Promotes Proliferation of Glioma Stem Cells and Modulates Their Inflammation Pathway Mainly through Post-Transcriptional Regulation.
Journal: International journal of molecular sciences
Published: March 21, 2022
Last Updated: 09/26/2026